Truist Securities analyst Danielle Brill raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $190.00 (from $105.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE